Your browser doesn't support javascript.
loading
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.
Ramchandren, Radhakrishnan; Domingo-Domènech, Eva; Rueda, Antonio; Trnený, Marek; Feldman, Tatyana A; Lee, Hun Ju; Provencio, Mariano; Sillaber, Christian; Cohen, Jonathon B; Savage, Kerry J; Willenbacher, Wolfgang; Ligon, Azra H; Ouyang, Jing; Redd, Robert; Rodig, Scott J; Shipp, Margaret A; Sacchi, Mariana; Sumbul, Anne; Armand, Philippe; Ansell, Stephen M.
Afiliación
  • Ramchandren R; 1University of Tennessee, Knoxville, TN.
  • Domingo-Domènech E; 2Barbara Ann Karmanos Cancer Institute, Detroit, MI.
  • Rueda A; 3Hospital Duran i Reynals, Barcelona, Spain.
  • Trnený M; 4Costa del Sol Hospital, Marbella, Spain, and Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.
  • Feldman TA; 5Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
  • Lee HJ; 6John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ.
  • Provencio M; 7University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sillaber C; 8Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Cohen JB; 9Medical University of Vienna, Vienna, Austria.
  • Savage KJ; 10Winship Cancer Institute, Emory University, Atlanta, GA.
  • Willenbacher W; 11British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, British Columbia, Canada.
  • Ligon AH; 12Innsbruck University Hospital, Innsbruck, Austria.
  • Ouyang J; 13OncoTyrol-Center of Personalized Cancer Medicine, Innsbruck, Austria.
  • Redd R; 14Brigham and Women's Hospital, Boston, MA.
  • Rodig SJ; 15Dana-Farber Cancer Institute, Boston, MA.
  • Shipp MA; 15Dana-Farber Cancer Institute, Boston, MA.
  • Sacchi M; 14Brigham and Women's Hospital, Boston, MA.
  • Sumbul A; 15Dana-Farber Cancer Institute, Boston, MA.
  • Armand P; 15Dana-Farber Cancer Institute, Boston, MA.
  • Ansell SM; 16Bristol-Myers Squibb, Princeton, NJ.
J Clin Oncol ; 37(23): 1997-2007, 2019 08 10.
Article en En | MEDLINE | ID: mdl-31112476
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Antineoplásicos Inmunológicos / Nivolumab / Estadificación de Neoplasias Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Túnez
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Antineoplásicos Inmunológicos / Nivolumab / Estadificación de Neoplasias Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Túnez